First direct assay for intact human proinsulin

Clin Chem. 1998 Jul;44(7):1514-9.

Abstract

We describe a sensitive two-site sandwich enzyme-linked immunosorbent assay for the measurement of intact human proinsulin in 100 microL of serum or plasma. The assay is based on the use of two monoclonal antibodies specific for epitopes at the C-peptide/insulin A chain junction and at the insulin B chain/C-peptide junction, respectively. Cross-reactivities with insulin, C-peptide, and the four proinsulin conversion intermediates were negligible. The detection limit in buffer was 0.2 pmol/L (3 standard deviations from zero). The working range was 0.2-100 pmol/L. The mean intra- and interassay coefficients of variation were 2.4% and 8.9%, respectively. The mean recovery of added proinsulin was 103%. Dilution curves of 40 serum samples are parallel to the proinsulin calibration curve. Proinsulin concentrations in 20 fasting healthy subjects were all above the limit of detection: median (range), 2.7 pmol/L (1.1-6.9 pmol/L). Six fasting non-insulin-dependent diabetes mellitus and five insulinoma patients had proinsulin concentrations significantly higher than healthy subjects: median (range), 7.7 pmol/L (3.2-18 pmol/L) and 153 pmol/L (98-320 pmol/L), respectively.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / immunology
  • C-Peptide / chemistry
  • C-Peptide / immunology
  • Cross Reactions
  • Diabetes Mellitus, Type 2 / blood
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Hypoglycemia / blood
  • Insulinoma / blood
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / blood
  • Proinsulin / blood*
  • Proinsulin / chemistry
  • Proinsulin / immunology
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Antibodies, Monoclonal
  • C-Peptide
  • Proinsulin